Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 170 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1691 4.0 months Recurent GBM Chemotherapy
University of Southern California, Norris Comprehensive Cancer Hospital, Department of Neurology United States 1/2002
Treatment Details: Patients: This Phase II study involved 40 patients with recurrent glioblastoma multiforme. All patients had already been treated with surgery and radiotherapy. Treatment: Treatment consi
 
1692 4.0 months hepatocellular carcinoma (inoperable) 4 Biologic therapy
Santa Clara Valley Medical Center United States 1/2005
Treatment Details: Patients: This Phase II study involved 27 patients with unresectable hepatocellular carcinoma, 21 men and 6 women. The median age was 62 years. Treatment: Treatment consisted of one bi
 
1693 4.0 months metastatic breast cancer 3 Biologic therapy
San Filippo Neri Hospital Italy 5/2005
Treatment Details: Patients: This study involved 12 patients with metastatic breast cancer. The median age of the women was 53.5 years, and all had previously been treated with at least two chemotherapy regim
 
1694 4.0 months Primary central nervous system lymphoma 5 Chemotherapy
Austin Health Australia 11/2012
Treatment Details: Patients: This study involved 7 pretreated, relapsed primary central nervous system lymphoma patients with a median age of 58 years, 5 of whom were male. Treatment: Patients received ch
 
1695 3.9 months Metastatic urothelial cancer 3 Biologic therapy
Fox Chase Cancer Center United States 10/2012
Treatment Details: Patients: This phase 2 study involved pretreated metastatic urothelial cancer patients who were divided into two separate treatment groups. There were 11 patients in group A with a median
 
1696 3.9 months Urothelial tract carcinoma 4 Biologic therapy
Fox Chase Cancer Center United States 10/2012
Treatment Details: Patients: This phase 2 study involved previously treated advanced urothelial tract carcinoma patients who were divided into two separated treatment groups. Group A consisted of 11 patients
 
1697 3.5 months Metastatic urothelial cancer 4 Biologic therapy
Lukas Hospital Germany 12/2012
Treatment Details: Patients: This phase 2 study involved 15 metastatic urothelial carcinoma patients who had been previously treated with platinum-based chemotherapy. The median patient age was 64.7 years an
 
1698 3.5 months Advanced metastatic renal cell carcinoma 3 Biologic therapy
California Pacific Medical Center United States 11/2002
Treatment Details: Patients: This Phase II study involved 29 patients with advanced metastatic renal cell carcinoma. The median age was 55. Nineteen had undergone previous nephrectomy and most had received o
 
1699 3.5 months Recurrent GBM 4 Chemotherapy
Hopital Europeen Georges Pompidou France 5/2003
Treatment Details: Patients: This multicentre Phase II trial involved 14 patients with recuurent glioblastoma multiforme. (14 patients were assessable for tumor response. 15 patients were assessable for toxi
 
1700 3.4 months GBM (recurrent) 4 Gene Therapy
Johns Hopkins United States 1/2005
Treatment Details: Patients: This phase II trial involved 21 patients. There were 15 men and 6 women and the average age was 49.7 years. Sixteen patients had malignant glioblastoma multiforme (GBM), one had
 
Page 170 of 187  | Previous Page  | Next Page